Leukemia inhibitory factor, a double-edged sword with therapeutic implications in human diseases is a research paper published in Molecular Therapy (2022). On theSindex it has a DataRank of 0. It has been cited 77 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01CA260838
National Institutes of Health
Grant: R01CA203965
CDMRP
Grant: W81XWH-18-10238
NCI NIH HHS
Grant: R01 CA227912
NCI NIH HHS
Grant: R01 CA260837
National Institutes of Health
Grant: 5R01CA227912-03
Metabolic reprogramming in breast cancer
National Institutes of Health
Grant: 1R01CA260838-01A1
The role of leukemia inhibitory factor in colorectal cancer
National Institutes of Health
Grant: 5R01CA203965-03
The role of chronic stress in regulation of mutant p53 and tumorigenesis
National Institutes of Health
Grant: 5R01CA260837-04
Gain-of-function mutant p53 and metabolic reprogramming in colorectal cancer
U.S. Department of Defense
FWCI
5.47
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals